echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Eur Radiol: How much do you know about MRI diagnosis of ovarian tumors?

    Eur Radiol: How much do you know about MRI diagnosis of ovarian tumors?

    • Last Update: 2021-03-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Ovarian cancer is the fifth leading cause of cancer deaths among women of all ages, more deaths than any other gynecological malignancy.


    Ovarian cancer is the fifth leading cause of cancer deaths among women of all ages, more deaths than any other gynecological malignancy.


    Magnetic resonance imaging (MRI) has high soft tissue resolution and has become an important examination method for ovarian disease at this stage.


    Recently, a study published in the journal European Radiology has developed a deep learning algorithm that uses convolutional neural networks on conventional MR imaging to identify benign and malignant ovarian lesions, and establishes a preoperative evaluation of non-invasive ovarian lesions.


    A total of 455 lesions (379 benign and 166 malignant) from 451 patients from a single institution were divided into training set, validation set and test set, with a ratio of 7:2:1.


    A total of 455 lesions (379 benign and 166 malignant) from 451 patients from a single institution were divided into training set, validation set and test set, with a ratio of 7:2:1.


    Compared with the average level of junior radiologists, the final combined model combining MR imaging and clinical variables has higher detection accuracy (0.


    a.


    a.


        This research report developed a deep learning algorithm based on conventional MR imaging and clinical variables to distinguish benign and malignant ovarian tumors.


    Original source: Original source:

    Robin Wang,Yeyu Cai,Iris K Lee,et al.


    Robin Wang,Yeyu Cai,Iris K Lee,et al.
    Evaluation of a convolutional neural network for ovarian tumor differentiation based on magnetic resonance imaging.
    DOI: org/10.
    1007/s00330-020-07266-x">10.
    1007/s00330-020-07266-x Robin Wang,Yeyu Cai,Iris K Lee, Evaluation of A Convolutional Al et Neural Network for ovarian tumor differentiation based Magnetic Resonance imaging.
    DOI oN:.
    org/10.
    1007/s00330-020-07266-x">10.
    1007 / s00330-020-07266 X-org/10.
    1007/s00330-020-07266-x"> 10.
    1007 / s00330-020-07266-X in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.